Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial
Jietao Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Lizhu Lin(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Wen‐Ming Chen(Guangzhou University of Chinese Medicine), Lingling Sun(Second Affiliated Hospital of Zhejiang University), Hanrui Chen(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Xinting Zheng(Huazhong Agricultural University), Yang Cao(Dalian Medical University), Ting Yang(Guangzhou University of Chinese Medicine), Xiangjun Qi(Guangzhou University of Chinese Medicine)
Cited by 5
Related Papers
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants
|Redox Biology|2024|193
Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma
|Chinese Medicine|2021|95
Transcriptome Reveals Long Non-coding RNAs and mRNAs Involved in Primary Wool Follicle Induction in Carpet Sheep Fetal Skin
|Frontiers in Physiology|2018|84